Combination therapy treat patients with metastatic castration-resistant prostate cancer
A new study has revealed FDA-approved trametinib and entinostat (which is currently in clinical trials) can be given […]
Updated Date: Fri, 10 Mar 2023 00:00:00 EST
Updated Date: Fri, 10 Mar 2023 00:00:00 EST
Updated Date: Fri, 10 Mar 2023 00:00:00 EST
Updated Date: Fri, 10 Mar 2023 00:00:00 EST
Updated Date: Fri, 10 Mar 2023 00:00:00 EST
GOSH will collaborate with Leucid at the Zayed Centre for Research into Rare Disease in Children
Therapy prevents tumour proliferation while breaking immune tolerance among cancer patients
